Physician profile
Michael A Young
NPI 1790230365
$703.29
in general payments reported to CMS, 2019-2025
9 companies · $113 in 2025
The $113 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.42 · 2020: $12.15 · 2021: $103 · 2022: $186 · 2023: $142 · 2024: $81.57 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $204.35 | 2021-2025 | Biohorizons Dental Implants |
| Kerr Corporation | $158.72 | 2022-2023 | Maxcem Elite, Zirconia Abutment Preparation Kit |
| Nobel Biocare USA | $124.51 | 2019-2023 | Nobelactive |
| Dentsply Sirona INC | $80.35 | 2020-2024 | Waveone Gold Conform Fit |
| Philips North America LLC | $53.51 | 2019-2023 | |
| Envista Holdings Corporation | $26.39 | 2024 | Optibond Fl |
| 3m Company | $25.05 | 2023 | 3m Relyx |
| Peter Brasseler Holdings, LLC | $15.35 | 2024 | |
| Align Technology, INC. | $15.06 | 2024 | Invisalign |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.